Expectant management of nonpalpable prostate cancer with curative intent: Preliminary results

Journal of Urology

Volumn 167, Issue 3, 2002, Pages 1231-1234

  Carter, H Ballentine ^a   Walsh, Patrick C ^a   Landis, Patricia ^a   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Patient case management; Prostatic neoplasm

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

EID: 0036160557     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65271-8     Document Type: Article

References (6)

1. The prostate cancer intervention versus observation trial: A randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer
2. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening
3. Pathologic and clinical findings to predict tumor extent of non-palpable (stage T1c) prostate cancer
4. Mean time to cancer-specific death of apparently clinically localized prostate cancer: Policy implications for threshold ages in prostate-specific antigen screening and ablative therapy
5. Prospective evaluation of men with stage T1c adenocarcinoma of the prostate
6. Importance of posterolateral needle biopsies in the detection of prostate cancer